CDKN2A and Parkinson disease: More importantly, we also demonstrated that metformin treatment reduced the expression of p16Ink4a, increased the nuclear lamin B1 level and decreased the secretion of several SASP factors in astrocytes in the MPTP-induced PD model mice.